Psoriasis is a chronic inflammatory skin condition that can cause raised, scaly, itchy, and sometimes painful patches. Treatment is not simply about removing visible scales. Modern psoriasis care focuses on reducing inflammation, clearing the skin as much as possible, preventing relapses, and identifying related conditions such as psoriatic arthritis.
For many people with mild psoriasis, dermatologists begin with topical treatment applied directly to affected skin.
Topical medicines can reduce inflammation, slow excessive skin-cell growth, soften scaling, and relieve itching. Common categories include:
The National Psoriasis Foundation lists topical steroids, vitamin D analogs, tar, and other topical therapies among established treatment approaches.
Topical corticosteroids are commonly prescribed because they can quickly reduce inflammation and itching.
Different strengths may be used depending on the body area. Stronger steroids may be appropriate for thick plaques on areas such as the elbows or knees, while weaker preparations may be preferred for thinner or more sensitive skin.
Long-term or inappropriate use of potent corticosteroids can cause side effects, so treatment should follow the prescribed schedule.
Vitamin D analogs such as calcipotriene can slow excessive skin-cell growth and are sometimes used alone or in combination with topical corticosteroids.
Combination treatment can allow different mechanisms to work together while reducing reliance on prolonged steroid use.
Newer prescription treatments have expanded topical choices.
For example, roflumilast is a steroid-free topical treatment approved for plaque psoriasis in certain age groups and body locations. The National Psoriasis Foundation lists both cream and foam formulations among recognized prescription treatments.
These newer options can be particularly useful when psoriasis affects areas where prolonged steroid treatment is less desirable.
When topical treatment is not enough, phototherapy can be another early treatment approach for selected patients.
Phototherapy uses controlled ultraviolet light to slow the abnormal growth and activity of skin cells involved in psoriasis.
Common forms include:
The National Psoriasis Foundation notes that narrowband UVB is widely used and can be administered in a clinic or, for appropriately selected patients, with a prescribed home phototherapy unit.
Narrowband UVB uses a specific range of ultraviolet wavelengths.
Treatment usually requires repeated sessions rather than a single exposure. Consistency is important for achieving and maintaining improvement.
A dermatologist determines the appropriate dose based on factors such as skin type, psoriasis severity, treatment response, and other medications.
For localized plaques, an excimer laser can deliver concentrated UVB to affected areas while minimizing exposure to unaffected skin.
The National Psoriasis Foundation notes that excimer treatment is FDA-approved for chronic localized psoriasis and may be particularly useful for some scalp psoriasis cases.
Phototherapy is not the same as simply spending more time in the sun. Medical phototherapy provides controlled dosing, whereas excessive natural ultraviolet exposure can cause burns and increase skin-cancer risk.
For psoriasis that is more extensive, difficult to control, or significantly affecting quality of life, dermatologists may consider systemic medication.
Systemic medicines work throughout the body rather than only where plaques are visible.
Established non-biologic systemic treatments include:
The AAD and National Psoriasis Foundation have published guidance addressing systemic non-biologic therapies, including their effectiveness, safety considerations, and appropriate use.
Methotrexate suppresses certain immune-system activities involved in psoriasis.
It can be effective for psoriasis and may also be useful when psoriatic arthritis is present.
Because methotrexate can affect the liver, blood cells, and other organs, medical monitoring is required.
Cyclosporine suppresses immune activity and can work relatively quickly.
Because of potential effects on blood pressure and kidney function, it is generally used selectively and with careful monitoring.
Acitretin is an oral retinoid that can be useful for certain forms of psoriasis.
It has important precautions and is not appropriate for everyone, particularly because of its significant pregnancy-related risks.
Apremilast works differently from traditional immunosuppressive medications and can be used for certain adults with psoriasis and psoriatic arthritis.
As with any systemic treatment, potential benefits and side effects should be discussed with a healthcare professional.
For many people with moderate-to-severe psoriasis, biologic therapies have become an important part of modern treatment.
Biologics are targeted medicines designed to block specific immune pathways involved in psoriasis rather than broadly suppressing the entire immune system.
Major biologic categories target pathways involving:
The AAD-NPF guidelines specifically address biologic therapies for moderate-to-severe psoriasis and their effectiveness and safety considerations.
The National Psoriasis Foundation describes biologics as an established treatment option for plaque psoriasis and psoriatic arthritis, particularly for people who have not responded adequately to other treatments or experienced problematic side effects.
Traditional systemic medications can affect several immune pathways.
Biologics are designed to target specific inflammatory signals.
This targeted approach has helped expand treatment possibilities for people whose psoriasis has not responded adequately to topical medicines or phototherapy.
However, biologics are prescription treatments and require medical evaluation, monitoring, and consideration of infection and other risks.
No.
A person with a few manageable plaques may do very well with topical treatment.
Another person with extensive psoriasis, severe symptoms, nail involvement, scalp disease, genital psoriasis, or substantial quality-of-life effects may benefit from advanced therapy.
The National Psoriasis Foundation's newer position on disease severity emphasizes that severity should not be determined solely by the percentage of body surface affected. Psoriasis affecting high-impact areas or failing to respond adequately to topical therapy can also warrant consideration of advanced treatments.
The location of psoriasis can influence treatment selection.
Thick scales and hair can make scalp treatment difficult.
Topical corticosteroids, vitamin D analogs, medicated preparations, and certain foams or solutions may be considered. Phototherapy or systemic treatment can also be used when scalp disease is difficult to control.
Facial skin is more delicate than skin on the elbows or knees.
Potent corticosteroids generally require particular caution in this area because prolonged use can cause skin thinning and other side effects.
Nail involvement can be difficult to treat with creams alone.
Depending on severity, systemic or biologic therapy may be considered, particularly when nail disease is associated with psoriatic arthritis.
Psoriasis affecting the palms and soles can significantly interfere with walking, working, and daily activities.
Even when the affected area is relatively small, its location can make the disease functionally severe.
Psoriasis affects more than skin.
Some people develop psoriatic arthritis, which can cause joint pain, stiffness, swelling, and reduced mobility.
Possible warning signs include:
The AAD-NPF approach emphasizes awareness of comorbidities and screening for associated conditions.
If joint symptoms are present, a dermatologist may coordinate care with a rheumatologist because treatment selection can change when both psoriasis and psoriatic arthritis are involved.
Prescription treatment is important, but basic skin care remains useful.
Regular moisturizing can help:
A thick, fragrance-free moisturizer or ointment may be especially useful after bathing.
Moisturizers do not eliminate the underlying inflammatory disease, but they can complement medical treatment.
Scratching plaques can cause additional irritation and sometimes contribute to new psoriasis lesions appearing at sites of skin injury.
Keeping nails short and using appropriate treatment to control itching can reduce the urge to scratch.
Persistent itching despite treatment should be discussed with a dermatologist because the treatment plan may need adjustment.
Diet can play a role in overall health, but there is no universal psoriasis diet that replaces medical treatment.
Maintaining a healthy weight, limiting alcohol, avoiding smoking, and following a balanced eating pattern can be beneficial for overall health and may be particularly relevant because psoriasis is associated with several cardiometabolic conditions.
The NPF specifically highlights lifestyle factors such as smoking and alcohol because they can affect psoriasis and associated health risks.
Psoriasis is a chronic condition that can improve and then flare again.
Stopping treatment as soon as plaques begin to improve can sometimes result in a rapid return of symptoms.
Treatment plans should therefore include both a strategy for achieving control and a plan for maintaining it.
The National Psoriasis Foundation's "treat to target" approach emphasizes measurable treatment goals rather than simply accepting persistent disease without reassessing therapy.
A dermatologist may consider several factors before recommending treatment:
This means two people with apparently similar psoriasis may receive very different treatment plans.
A simplified treatment pathway can look like this:
Mild psoriasis
→ Topical treatment
Persistent or more widespread disease
→ Phototherapy and/or systemic treatment
Moderate-to-severe or high-impact disease
→ Oral systemic or biologic therapy may be considered
Psoriatic arthritis or difficult-to-control disease
→ Coordinated dermatology and rheumatology care may be appropriate
This is not a fixed sequence. Some patients may move directly to advanced treatment when disease severity, location, quality-of-life impact, or previous treatment failure warrants it.
Modern psoriasis treatment increasingly focuses on achieving clear or almost-clear skin rather than simply making the condition "a little better."
The National Psoriasis Foundation notes that treatment targets provide measurable goals that can help patients and clinicians determine whether a treatment is working adequately.
If a treatment is not producing sufficient improvement, a dermatologist may adjust the dose, combine treatments, or switch to another therapy.
The four major treatment approaches dermatologists may consider early in psoriasis management are topical medications, phototherapy, oral systemic treatments, and biologic therapies. The appropriate starting point depends on disease severity, affected areas, symptoms, associated conditions, previous treatment response, and individual circumstances.